Dr. Wenhao Cai is a clinician–scientist specializing in acute pancreatitis (AP) based at West China Hospital, Sichuan University. He began his postgraduate training at West China Hospital in 2015 and pursued his Ph.D. at the University of Liverpool from 2018 to 2023. His research focuses on the pathogenesis, biomarkers, clinical risk prediction, and therapeutic interventions of AP, including studies integrating traditional Chinese medicine approaches. To date, he has published over 30 academic papers in peer-reviewed journals, including Gut, Drugs, and Phytomedicine. His work has been recognized with international conference awards and competitive research funding.
Dr. Wenhao Cai is a clinician–scientist specializing in acute pancreatitis (AP) based at West China Hospital, Sichuan University. He began his postgraduate training at West China Hospital in 2015 and pursued his Ph.D. at the University of Liverpool from 2018 to 2023. His research focuses on the pathogenesis, biomarkers, clinical risk prediction, and therapeutic interventions of AP, including studies integrating traditional Chinese medicine approaches. To date, he has published over 30 academic papers in peer-reviewed journals, including Gut, Drugs, and Phytomedicine. His work has been recognized with international conference awards and competitive research funding.